Kosmix
One sec... we're building your guide for
Tocilizumab
Tocilizumab
Overview
Main ›
Reference ›
News & Blogs ›
Patient Experiences ›
Video ›
Tools
›
WebMD
Health Check: Are You Doing All You Can to Manage Your Rheumatoid Arthritis?
Related in the Kosmos
?
Immunosuppressants
(32)
Abatacept
Abetimus
Adalimumab
Afelimomab
Anakinra
Anakinra
Certolizumab pegol
Daclizumab
Eculizumab
Mepolizumab
Methotrexate
Ustekinumab
Alefacept
Anti-thymocyte globulin
Azathioprine
Basiliximab
Ciclosporin
Efalizumab
Etanercept
Everolimus
Gusperimus
Infliximab
Leflunomide
Lenalidomide
Muromonab-CD3
Mycophenolate mofetil
Mycophenolic acid
Natalizumab
ReciGen
Rilonacept
Sirolimus
Tacrolimus
Thalidomide
more...
Monoclonal antibodies
(186)
Aflibercept
Afutuzumab
Alacizumab pegol
Alemtuzumab
Apolizumab
Apolizumab
Aselizumab
Bevacizumab
Bivatuzumab mertansine
Cantuzumab mertansine
Cedelizumab
Citatuzumab bogatox
Clenoliximab
Dorlixizumab
Erlizumab
Etaracizumab
Farletuzumab
Felvizumab
Fontolizumab
Gantenerumab
Golimumab
Gomiliximab
Humanized
Inotuzumab ozogamicin
Lebrilizumab
Maslimomab
Milatuzumab
Nerelimomab
Ocrelizumab
Omalizumab
Oportuzumab monatox
Pascolizumab
Pexelizumab
Reslizumab
Rovelizumab
Ruplizumab
Sibrotuzumab
Siplizumab
Solanezumab
Tacatuzumab tetraxetan
Tadocizumab
Talizumab
Tefibazumab
Teneliximab
Teplizumab
Tigatuzumab
Toralizumab
Tucotuzumab celmoleukin
Urtoxazumab
Vapaliximab
Vedolizumab
Vepalimomab
Visilizumab
3F8
Abagovomab
Abatacept
Abciximab
Abzyme
Adalimumab
Adecatumumab
Afelimomab
Altumomab
Anatumomab mafenatox
Atorolimumab
Bapineuzumab
Basiliximab
Bavituximab
Bectumomab
Belatacept
Belimumab
Bertilimumab
Besilesomab
Biciromab
Bispecific monoclonal antibody
Blinatumomab
Brentuximab vedotin
Cambridge Antibody Technology
Canakinumab
Catumaxomab
Certolizumab pegol
Cetuximab
Cixutumumab
Conatumumab
Dacetuzumab
Daclizumab
Denosumab
Detumomab
Ecromeximab
Eculizumab
Edobacomab
Edrecolomab
Efalizumab
Efungumab
Elotuzumab
Elsilimomab
Epratuzumab
Ertumaxomab
Etanercept
Exbivirumab
Faralimomab
Figitumumab
Foravirumab
Fresolimumab
Galiximab
Gavilimomab
Gemtuzumab ozogamicin
HuMax
Ibalizumab
Ibritumomab tiuxetan
Igovomab
Imciromab
Indium (111In) capromab pendetide
Indium (111In) satumomab pendetide
Infliximab
Inolimomab
Ipilimumab
Iratumumab
Keliximab
Labetuzumab
Lemalesomab
Lerdelimumab
Lexatumumab
Libivirumab
Lintuzumab
List of monoclonal antibodies
Lucatumumab
Lumiliximab
Mapatumumab
Matuzumab
Mepolizumab
Metelimumab
Minretumomab
Mitumomab
Morolimumab
Motavizumab
Nacolomab tafenatox
Naptumomab estafenatox
Natalizumab
Nebacumab
Necitumumab
Nimotuzumab
Nomenclature of monoclonal antibodies
Odulimomab
Ofatumumab
Oregovomab
Otelixizumab
PRO 140
Pagibaximab
Palivizumab
Panitumumab
Panobacumab
Pemtumomab
Personalized medicine
Pertuzumab
Priliximab
Pritumumab
Rafivirumab
Ramucirumab
Ranibizumab
Raxibacumab
Regavirumab
Rilonacept
Rituximab
Robatumumab
Sevirumab
Siltuximab
Stamulumab
TGN1412
Tanezumab
Taplitumomab paptox
Technetium (99mTc) arcitumomab
Technetium (99mTc) fanolesomab
Technetium (99mTc) nofetumomab merpentan
Technetium (99mTc) pintumomab
Technetium (99mTc) sulesomab
Technetium (99mTc) votumumab
Telimomab aritox
Tenatumomab
Trastuzumab
Tremelimumab
Tuvirumab
Ustekinumab
Veltuzumab
Volociximab
Zalutumumab
Zanolimumab
Zolimomab aritox
more...
Immune system
(8)
Immunosuppressive
Antigen
Immunosuppressants
Monoclonal antibody
Toralizumab
Toralizumab
Vedolizumab
Visilizumab
Humanized
more...
Immunology
DMARDs
Monoclonal antibody
Humanized
Immunosuppressive
Hoffmann-La Roche
(10)
Chugai Pharmaceuticals
Roche Applied Science
Afutuzumab
Diazepam
Flunitrazepam
Flunitrazepam
Genentech
Hoffmann–La Roche
Leo Sternbach
Orlistat
Polymerase chain reaction
more...
Rheumatology
Arthritis
EULAR
Juvenile idiopathic arthritis
Rheumatic diseases
American College of Rheumatology
Pharmacology
Drugs
Monotherapy
Biologics
Certolizumab pegol
See also
(20)
ATC code L04
IL-6 receptor
Chemical substances
Purine synthesis inhibitor
Anti-lymphocyte globulin
Anti-lymphocyte globulin
Anatomical Therapeutic Chemical Classification System
Rheumatoid arthritis
TNF inhibitor
Medical University of Vienna, Austria
Interleukin 6
CTLA-4
Anti-tumor
Yokohama City University
Phase III
Signs and symptoms
Necrosis
Musculoskeletal
Enzyme inhibitor
Placebo in history
Lancelet
more...
more categories...
Health Providers & Organizations
›
Vitals.com
